Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study

NCT02263638 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT02263638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02263638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Lead sponsor
Rennes University Hospital
Phase
Phase 2
Overall status
Terminated
Start date
February 4, 2015
Completion date
September 4, 2018
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

refractory hemochromatosis rheumatism